Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.25% is 22% above its 5-year average of 8.38%, near the high end of its 5-year range (6.65%–10.25%).
18.09% above its 12-month average of 8.68%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.66%.
RETURN ON ASSETS (ROA)
10.25%
RETURN ON ASSETS (ROA) AVG TTM
8.68%
RETURN ON ASSETS (ROA) AVG 3Y
8.17%
RETURN ON ASSETS (ROA) AVG 5Y
8.38%
RETURN ON ASSETS (ROA) AVG 10Y
9.76%
RETURN ON ASSETS (ROA) AVG 15Y
7.92%
RETURN ON ASSETS (ROA) AVG 20Y
6.50%
CURRENT VS TTM AVG
+18.09%
CURRENT VS 3Y AVG
+25.42%
CURRENT VS 5Y AVG
+22.34%
CURRENT VS 10Y AVG
+5.06%
CURRENT VS 15Y AVG
+29.38%
CURRENT VS 20Y AVG
+57.69%
SECTOR MEDIAN · HEALTHCARE
-27.35%
median of 539 covered companies
CURRENT VS SECTOR MEDIAN
+137.48%
vs the sector median at left
LeMaitre Vascular, Inc.
Market Cap
$1.83B
Return on Assets (ROA)
10.25%
TTM Avg
8.68%
3Y Avg
8.17%
5Y Avg
8.38%
Market Cap
$1.86B
Return on Assets (ROA)
-37.11%
TTM Avg
4.34%
3Y Avg
-11.90%
5Y Avg
4.27%
Market Cap
$1.86B
Return on Assets (ROA)
1.78%
TTM Avg
2.10%
3Y Avg
3.84%
5Y Avg
3.40%
Market Cap
$1.80B
Return on Assets (ROA)
-46.66%
TTM Avg
-46.30%
3Y Avg
-40.19%
5Y Avg
-33.55%
Market Cap
$1.89B
Return on Assets (ROA)
11.27%
TTM Avg
-4.02%
3Y Avg
-13.89%
5Y Avg
-9.34%
Market Cap
$1.76B
Return on Assets (ROA)
-61.53%
TTM Avg
-47.53%
3Y Avg
-47.53%
5Y Avg
-47.53%
Market Cap
$1.72B
Return on Assets (ROA)
3.18%
TTM Avg
-8.22%
3Y Avg
-16.26%
5Y Avg
-17.13%
Market Cap
$1.74B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$1.93B
Return on Assets (ROA)
-45.02%
TTM Avg
-50.76%
3Y Avg
-46.27%
5Y Avg
-37.50%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.83B | 10.25% | 8.68% | 8.17% | 8.38% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | -37.11% | 4.34% | -11.90% | 4.27% |
| Astrana Health, Inc. (ASTH)vs › | $1.86B | 1.78% | 2.10% | 3.84% | 3.40% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.80B | -46.66% | -46.30% | -40.19% | -33.55% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 11.27% | -4.02% | -13.89% | -9.34% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.76B | -61.53% | -47.53% | -47.53% | -47.53% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | 3.18% | -8.22% | -16.26% | -17.13% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -10.49% | -13.41% | -10.26% | -6.23% |
| Absci Corporation (ABSI)vs › | $1.93B | -45.02% | -50.76% | -46.27% | -37.50% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -11.05% | -19.34% | -25.88% | -26.23% |
ROA
10.3%
ROE
15.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 9.38% |
| 2024-12-31 | 7.98% |
| 2023-12-31 | 8.68% |
| 2022-12-31 | 6.65% |
| 2021-12-31 | 9.19% |
| 2020-12-31 | 8.39% |
| 2019-12-31 | 9.52% |
| 2018-12-31 | 14.99% |
| 2017-12-31 | 13.60% |
| 2016-12-31 | 10.39% |
| 2015-12-31 | 8.55% |
| 2014-12-31 | 4.80% |
| 2013-12-31 | 4.54% |
| 2012-12-31 | 4.08% |
| 2011-12-31 | 3.59% |
| 2010-12-31 | 9.50% |
| 2009-12-31 | 2.81% |
| 2008-12-31 | -6.09% |
| 2007-12-31 | -4.80% |
| 2006-12-31 | -2.06% |
| 2005-12-31 | 0.22% |
| 2004-12-31 | 4.52% |
| 2003-12-31 | 0.00% |
| 2002-12-31 | 3.80% |
| 2001-12-31 | -4.97% |
